Fried Eiko I, Nesse Randolph M
University of Leuven, Faculty of Psychology and Educational Sciences, Research Group of Quantitative Psychology and Individual Differences, Tiensestraat 102, 3000 Leuven, Belgium.
Arizona State University, The Center for Evolution & Medicine, Tempe, AZ, USA.
J Affect Disord. 2015 Feb 1;172:96-102. doi: 10.1016/j.jad.2014.10.010. Epub 2014 Oct 14.
The DSM-5 encompasses a wide range of symptoms for Major Depressive Disorder (MDD). Symptoms are commonly added up to sum-scores, and thresholds differentiate between healthy and depressed individuals. The underlying assumption is that all patients diagnosed with MDD have a similar condition, and that sum-scores accurately reflect the severity of this condition. To test this assumption, we examined the number of DSM-5 depression symptom patterns in the "Sequenced Treatment Alternatives to Relieve Depression" (STAR*D) study.
We investigated the number of unique symptom profiles reported by 3703 depressed outpatients at the beginning of the first treatment stage of STAR*D.
Overall, we identified 1030 unique symptom profiles. Of these profiles, 864 profiles (83.9%) were endorsed by five or fewer subjects, and 501 profiles (48.6%) were endorsed by only one individual. The most common symptom profile exhibited a frequency of only 1.8%. Controlling for overall depression severity did not reduce the amount of observed heterogeneity.
Symptoms were dichotomized to construct symptom profiles. Many subjects enrolled in STAR*D reported medical conditions for which prescribed medications may have affected symptom presentation.
The substantial symptom variation among individuals who all qualify for one diagnosis calls into question the status of MDD as a specific consistent syndrome and offers a potential explanation for the difficulty in documenting treatment efficacy. We suggest that the analysis of individual symptoms, their patterns, and their causal associations will provide insights that could not be discovered in studies relying on only sum-scores.
《精神疾病诊断与统计手册》第五版(DSM - 5)涵盖了重度抑郁症(MDD)的广泛症状。症状通常被累加为总分,通过阈值区分健康个体和抑郁个体。潜在的假设是,所有被诊断为MDD的患者都有相似的病情,且总分能准确反映病情的严重程度。为检验这一假设,我们在“缓解抑郁的序贯治疗替代方案”(STAR*D)研究中检查了DSM - 5抑郁症状模式的数量。
我们调查了STAR*D研究第一个治疗阶段开始时3703名门诊抑郁症患者报告的独特症状概况数量。
总体而言,我们识别出1030种独特的症状概况。在这些概况中,864种概况(83.9%)被5名或更少的受试者认可,501种概况(48.6%)仅被1名个体认可。最常见的症状概况出现频率仅为1.8%。控制总体抑郁严重程度并未减少观察到的异质性数量。
症状被二分法处理以构建症状概况。许多参与STAR*D研究的受试者报告了一些医疗状况,其所用的处方药可能影响了症状表现。
所有符合单一诊断标准的个体之间存在大量症状差异,这使人质疑MDD作为一种特定一致综合征的地位,并为记录治疗效果的困难提供了一个潜在解释。我们建议,对个体症状、其模式及其因果关联的分析将提供仅依赖总分的研究中无法发现的见解。